News

Biocon Biologics gets FDA nod for Roche's bevacizumab biosimilar
Biocon Biologics, a subsidiary of India-based Biocon Ltd, said on Thursday that U.S. FDA has approved Jobevne, a biosimilar ...
Biocon Biologics secures USFDA approval for cancer treatment biosimilar
Biocon Biologics, a subsidiary of Biocon Ltd, announced on Thursday that it has received approval from the United States Food ...
Drug Store News4h
Biocon Biologics obtains FDA nod for Avastin biosimilar
Biocon Biologics has received the Food and Drug Administration’s green light for Jobevne (bevacizumab-nwgd), a biosimilar ...
Targeted Oncology2h
FDA Greenlights Bevacizumab Biosimilar Across Cancer Types
The FDA has approved bevacizumab-nwgd, a biosimilar to bevacizumab, for intravenous use across multiple cancer types.
Medscape12h
Cardiac Dysfunction Surfaces Early With Cancer Treatment
Cardiac problems associated with vascular endothelial growth factor inhibitors occur frequently in patients with cancer.
Medscape7d
Sponsor Pulls Plug on Trials of Add-On AMD Treatment
An add-on agent designed to boost drugs that treat age-related macular degeneration failed to show any benefit in two phase 3 ...
Verywell Health on MSN3d
Which Eye Specialist Treats Wet AMD?
Ophthalmologists specialize in wet AMD diagnosis and treatment. Learn about first steps toward diagnosis and treatment.
AHA/ASA Journals9d
Lymphatic Endothelial Branched-Chain Amino Acid Catabolic Defects Undermine Cardiac Lymphatic Integrity and Drive HFpEF
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) has become the most prevalent type of heart failure, but effective treatments are lacking. Cardiac lymphatics play a crucial role in ...